Microfluidic Droplet Barcoding for High-Throughput Nucleic Acid Sequencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nucleic acid sequencing technologies face challenges in efficiently barcoding and analyzing multiple samples in parallel, particularly for high-throughput genomic, transcriptomic, and proteomic applications, especially at the single cell and single virus level.
Innovation Solution
Microfluidic, droplet-based methods for barcoding nucleic acid target molecules, utilizing nucleic acid barcodes and unique molecular identifiers (UMIs) to label and sequence nucleic acids in discrete entities, enabling high-throughput analysis and profiling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional nucleic acid sequencing methods are used to analyze multiple samples in parallel, then throughput is limited, but device complexity and processing time increase
Solution Approach 1:
The patent divides the sequencing process into discrete droplet compartments, each containing individual nucleic acid molecules or cells with unique barcodes. This segmentation enables parallel processing of multiple samples simultaneously while maintaining simple, standardized droplet-based reaction units that can be handled by conventional microfluidic devices.
Solution Approach 2:
The patent implements a nested barcode system where multiple levels of barcodes (cell barcodes, molecule barcodes, and UMI s) are embedded within each other. This nested structure allows hierarchical tracking of samples from cell to molecule level, enabling high-throughput parallel analysis while using a unified, scalable barcode architecture that doesn't require fundamentally new device components.
2Productivity
If barcoding is performed on multiple nucleic acid molecules simultaneously, then sequencing efficiency improves, but accuracy of individual molecule identification deteriorates
Solution Approach 1:
The patent uses Unique Molecular Identifier s (UMI s) as digital copies or fingerprints for each individual nucleic acid molecule. These UMI s are incorporated during barcoding and serve as unique identifiers that can be tracked through amplification and sequencing processes, enabling accurate reconstruction of original molecule sequences even when multiple molecules are processed simultaneously.
Solution Approach 2:
The patent introduces barcode sequences as intermediary elements that bridge the original nucleic acid molecules and the sequencing detection system. These barcodes act as mediators that carry identification information through various processing steps, allowing individual molecule tracking to be maintained even during bulk parallel processing operations.
3Productivity
If high-throughput parallel sequencing is implemented, then analysis speed increases, but error rates in barcode assignment increase
Solution Approach 1:
The patent implements feedback mechanisms through the barcode design where UMI s provide verification information that can be used to detect and correct assignment errors. By incorporating these molecular fingerprints into the barcode structure, the system can feedback on the accuracy of molecule-barcode associations and identify potential errors in high-throughput processing.
Solution Approach 2:
The patent incorporates error-correcting capabilities into the barcode design beforehand, using redundant information in the UMI s and barcode structure to cushion against potential assignment errors. This prior cushioning allows the system to tolerate and correct errors that may occur during high-speed parallel processing without compromising overall reliability.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Microfluidic methods for barcoding nucleic acid target molecules to be analyzed, e.g. via nucleic acid sequencing techniques, are provided. Also provided are microfluidic, droplet-based methods of preparing nucleic acid barcodes for use in various barcoding applications. The methods described herein facilitate high-throughput sequencing of nucleic acid target molecules as well as single cell and single virus genomic, transcriptomic, and/or proteomic analysis/profiling. Systems and devices for practicing the subject methods are also provided.